| Patent application number | Description | Published |
|---|
| 20080269302 | Macrocyclic Tertiary Amine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease - The present invention is directed to macrocyclic tertiary amine compounds represented by general formula (I) | 10-30-2008 |
| 20080318927 | Substituted monocyclic CGRP receptor antagonists - Compounds of formula I: | 12-25-2008 |
| 20090105219 | Spirolactam Tricyclic CGRP Receptor Antagonists - Compounds of formula I: | 04-23-2009 |
| 20090176757 | Bicyclic Spirohydantoin CGRP Receptor Antagonists - Compounds of formula I: | 07-09-2009 |
| 20090247514 | Spirolactam aryl cgrp receptor antagonists - Compounds of formula I: | 10-01-2009 |
| 20090325991 | Spirolactam Bicyclic CGRP Receptor Antagonists - Compounds of formula I: | 12-31-2009 |
| 20100056498 | SUBSTITUTED MONOCYCLIC CGRP RECEPTOR ANTAGONISTS - Compounds of formula I: | 03-04-2010 |
| 20100069359 | CONSTRAINED SPIROCYCLIC COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS - Compounds of formula I: | 03-18-2010 |
| 20100093759 | BICYCLIC ANILIDE HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS - Compounds of formula I: I (wherein variables A1, A2, B, m, n, J, R4, G1, G2, G3 and Y are as described herein) which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved. | 04-15-2010 |
| 20100120809 | ARYL HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS - Compounds of formula I: | 05-13-2010 |
| 20100152216 | MONOCYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS - The present invention is directed to compounds of Formula I: | 06-17-2010 |
| 20100210693 | BENZYLETHER AND BENZYLAMINO BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - The present invention is directed to compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved. | 08-19-2010 |
| 20110021516 | MONOCYCLIC CGRP RECEPTOR ANTAGONISTS - The present invention is directed to compounds of the formula (I): (wherein variables A | 01-27-2011 |
